At Bloom Burton, we pride ourselves on having intimate knowledge of the health care industry and particularly drug and device development. We have direct experience in drug development and we know the challenges that health care companies face in today's environment. Our research presents detailed insight into companies, competitors and development strategies. We use our expertise to provide critical information to drive the investment decisions of our clients.

Research coverage:

• Æterna Zentaris Inc. (NASDAQ:AEZS; TSX:AEZ)
• Cardiome Pharma Corp. (NASDAQ:CRME; TSX:COM)
• CML HealthCare Inc. (TSX:CLC)
• CRH Medical Corp. (TSX:CRH)
• Medicago Inc. (TSX:MDG)
• Nuvo Research Inc. (TSX:NRI)
• OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI)
• Oncolytics Biotech Inc. (TSX:ONC; NASDAQ:ONCY)
• Paladin Labs Inc. (TSX:PLB)
• QLT Inc. (NASDAQ:QLTI; TSX:QLT)
• Theratechnologies Inc. (TSX:TH)
• Transition Therapeutics Inc. (TSX:TTH; NASDAQ:TTHI)

Bloom Burton & Co. Healthcare Speaker Series:
Understanding and profiting from a changing healthcare landscape.

• DECEMBER 16, 2010: The Generic Approach
  Guest Speaker: Hank Klakurka
• NOVEMBER 23, 2010: The Impact of Government on Pharma and Pharmacy Profitability
  Guest Speaker: Helen Stevenson

In the Media:

May 16, 2013: Canada's largest healthcare-specialized investment banking group, Bloom Burton & Co., is holdings its second annual Healthcare Investor Conference next week in Toronto. Business Day previews the event and talks investing ideas in biotech with Bloom Burton research analyst Philippa Flint.

NOVEMBER 20, 2012: In late July, she said they were a buy. How have they performed since? Business Day on the Business News Network conducts a check-up on the biotech stock recommendations of Philippa Flint, equity research analyst, Bloom Burton & Company.

JULY 12, 2012: The Life Sciences Report interviews Philippa Flint, equity research analyst at Bloom Burton & Co., for her insight into Canada's healthcare companies.

JULY 9, 2012: Philippa Flint, equity research analyst at Bloom Burton & Co., discusses QLT Inc. and Cardiome Pharma Corp. on the Business News Network

JUNE 22, 2010: Equity research analyst Philippa Flint discusses the potential investment appeal of diagnostic companies